We Need Your Urgent Help To Sustain This Website And All Our Research And Community Initiatives. Please Help By Donating To Our Cause. Go To The Sponsorship Section.

BREAKING NEWS
Source: COVID-19 Research  Nov 02, 2021  1 month ago
COVID-19 Research: German Researchers from the Otto-Von-Guericke-University Magdeburg, University Hospital Leipzig, Jena University Hospital and the  German Center for Mental Health (DZP) along with support from the University of Campinas (UNICAMP)-Brazil have in a new study found that individuals with SARS-CoV-2 infections can develop secondary occurrence of Anti-NMDAR Encephalitis due to mo...
Source: Thailand Medical  Nov 02, 2021  1 month ago
Coronavirus News: Researchers from the College of Veterinary Medicine, Kansas State University-USA have reported a case study involving a dog being infected with a new Delta sub-variant called AY.3. To date, it must be noted that there is literally no concerted effort of genomic sequencings of samples taken from domestic animals or even wild animals let alone constant testing to see if they have b...
Source: COVID-19-Eyes  Nov 01, 2021  1 month ago
COVID-19-Eyes: A study by researchers from University of Santiago de Compostela-Spain and the University Hospital of Santiago de Compostel-Spain has found that the infectious form of the SARS-CoV-2 virus is present in the tears and ocular secretions of individuals with COVID-19.   The study team investigated the presence of SARS-CoV-2 in conjunctival secretions and tears and evaluated ocular...
Source: Germany's Medical News  Nov 01, 2021  1 month ago
Germany’s COVID-19 News: Angela Merkel, Germany’s Chancellor sounded the alarm on Saturday over the return of a "certain degree of laziness and recklessness" as COVID-19 infection and death rates climb in Germany.   It was reported that more people in Germany are infected with the SARS-CoV-2 coronavirus than at the same point in 2020: according to the federal government...
Source: SARS-CoV-2 Research  Nov 01, 2021  1 month ago
SARS-CoV-2 Research: A new breakthrough vitro study by researchers from Department of Molecular Biosciences of the Wenner–Gren Institute-Stockholm University and also from the Department of Clinical Microbiology, Virology-Umeå University has found that the SARS-CoV-2 Spike proteins not only impairs DNA repair in the cells of the infected human host but that it also inhibits V(D)J recom...
Source: COVID-19 Drugs  Oct 31, 2021  1 month ago
COVID-19 Drugs: A new study by German researchers from the Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hannover Medical School, German Lung Research Center (DZL) and the German Center for Infection Research (DZIF), along with support by experts from University of Copenhagen-Denmark and the University of Kent-UK has found that drugs that target t...
Source: COVID-19 News  Oct 31, 2021  1 month ago
COVID-19 News: A new study by researchers from Harvard Medical School and Massachusetts Institute of Technology has confirmed that the SARS-CoV-2 coronavirus is able to infect the inner ears, causing a variety of conditions resulting from audiovestibular dysfunction.   The study team reported a series of ten COVID-19 patients with audiovestibular symptoms such as hearing loss, vestibula...
Source: SARS-CoV-2 Research  Oct 30, 2021  1 month ago
American scientists from the University of Utah Health are leading a new urgent effort to determine if salivary glands infected with the SARS-CoV-2 virus that causes COVID-19 could diminish a person's long-term immunity to the disease after being immunized or after recovering from the illness. Th new study aims to clarify after many researchers are sounding new alarms that the SARS-CoV-2 could...
Source: COVID-19 Immunology  Oct 29, 2021  1 month ago
COVID-19 Immunology: A new study by German researchers from the Ludwig Maximilian University of Munich (LMU), University of Bonn and the Technical University of Munich has found that SARS-CoV-2 reduces the numbers and functional competence of certain types of immune cells in the blood, ie dendritic cells and affect responses to secondary infections.   The study team analyzed circulating...
Source: B.1.620 Lineage  Oct 29, 2021  1 month ago
B.1.620 Lineage: According to a new multinational research led by researchers from Lithuania, a new SARS-CoV-2 Lineage called B.1.620 has emerged from most probably Cameroon in Central Africa and has spreading silently across the globe silently while the world was more focused on the Delta variant and its emerging sub-variants.   This new immune evasive variant B.1.620 not only exhibits...
Source: China COVID-19 News  Oct 28, 2021  1 month ago
China COVID-19 News: China is bracing for the worse as more transmissible forms of the SARS-CoV-2 Delta subvariants have been found in the country as infections emerge. To date it is reported that tfour different Delta Sub-variants ie AY.23, AY.25, AY.37 and AY.4.2 have been found in the country according to virologists from the Chinese Academy of Sciences and also from the Pasteur Institute-Shang...
Source: COVID-19 Drugs  Oct 28, 2021  1 month ago
Fluvoxamine-COVID-19: The results from the TOGTHER clinical trial has shown that fluvoxamine reduces the risk of COVID-19 disease severity and reduces the need for hospitalization.   The TOGETHER trial is a randomized, adaptive platform trial to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. The trial was designed and done in partner...
Source: ADE-SARS-CoV-2  Oct 27, 2021  1 month ago
The alarming study findings by researchers from the Faculty of Medicine, Lund University-Sweden, Public Health Agency of Sweden, Adlego Biomedical AB-Sweden, Tanea Medical Ab-Sweden, jSciEd Solutions-Sweden, University of Zurich-Switzerland and Ecole Normale Superieure Paris-Saclay-France indicates that the normal type of ADE or Antibody-enhancement phenomena that most were expecting to be ma...
Source: SARS-CoV-2 A.30 Variant  Oct 27, 2021  1 month ago
SARS-CoV-2 A.30 Variant: German researchers from Georg-August-University Göttingen, the German Primate Center, Friedrich-Alexander University of Erlangen-Nürnberg and Hannover Medical School have found in that the newly emerging SARS-CoV-2 variant A.30 is almost totally evasive to antibodies generated by current COVID-19 vaccines!   The study findings were published in th...
Source: Autophagy-SARS-CoV-2  Oct 26, 2021  1 month ago
Autophagy-SARS-CoV-2: A review published by a researcher, Dr Theo Rein from the Max Planck Institute of Psychiatry, Munich-Germany in the peer reviewed Journal of Cellular Biochemistry highlights the importance of autophagy in the fight against SARS-CoV-2 infections and also identifies potential drugs that could be repurposed to treat COVID-19. https://onlinelibrary.wiley.com/doi/10.1002/jcb.30166...
Source: Delta-sub-variants   Oct 26, 2021  1 month ago
A new study lead by the Broad Institute of Harvard and MIT, Cambridge-USA and the MADPH (Massachusetts Department of Public Health) has confirmed that fully vaccinated individuals are responsible for transmitting and spreading the new Delta sub-variants including the the AY.25 sub-variant which has been responsible for a surge in Massachusetts.   Multiple summer events, including large indoo...
Source: COVID-19 Drugs  Oct 25, 2021  1 month ago
COVID-19 Drugs: A new multinational research involving medical scientists from Aarhus University-Denmark, Istituto Pasteur Italia-Cenci Bolognetti Foundation-Italy, University of Ottawa-Canada and Ottawa Hospital Research Institute-Canada has found that the U.S, FDA approved antimicrobial drug Atovaquone has antiviral potential against the SARS-CoV-2 coronavirus and emerging VOCs and could be repu...
Source: SARS-CoV-2 Mutations-Immune Evasion  Oct 25, 2021  1 month ago
SARS-CoV-2 Mutations-Immune Evasion: A new study by researchers from the Data Science Department, SOPHiA GENETICS-Switzerland has found that mutations at a hotspot W152 of the N-Terminal Domain (NTD) of the SARS-CoV-2 virus is driving immune evasion.   The study team reported a striking increase in the frequency of recruitment of diverse substitutions at a critical residue (W152), positioned...
Source: World COVID-19 News  Oct 24, 2021  1 month ago
World COVID-19 News: COVID Rate Hits Highest Level Since May For Germany   It was reported that Germany's seven-day coronavirus incidence rate reached 100 infections per 100,000 people on Saturday for the first time since May, following a surge in cases in recent weeks. The number hit 100 after rising from 68.7 just eight days ago, the Robert Koch health institute (RKI) said. ...
Source: COVID-19 Alarms!  Oct 24, 2021  1 month ago
(Note: Before reading this article, with winter fast approaching, and more Delta sub-variants emerging along with other new variants and recombinant strains, we strongly advised that everyone gets vaccinated fast especially since a majority are ignorant and do not have access to other protocols that can ward off these emerging variants.(We are not talking about Ivermectin which does not work on th...
Source: NeuroCOVID  Oct 24, 2021  1 month ago
NeuroCOVID: A new study by researchers from the Institute for Experimental and Clinical Pharmacology and Toxicology, Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck-Germany has alarmingly found that the SARS-CoV-2 main protease mpro causes microvascular brain pathology cleaving NEMO (The essential modulator of nuclear factor-κB) in brain endotheli...
Source: Cognitive Issues and COVID-19  Oct 23, 2021  1 month ago
Cognitive Issues and COVID-19: A new study by researchers from Icahn School of Medicine at Mount Sinai, New York has shown that that cognitive decline and brain fog can persist up to 8 months after contracting COVID-19! Individuals who have survived COVID-19 frequently complain of cognitive dysfunction, which has been described as brain fog. The prevalence of post–COVID-19 cognitive im...
Source: Singapore COVID-19 News  Oct 22, 2021  1 month ago
The current COVID-19 surges in Singapore are being driven by a new Delta Sub-variant identified as AY.23. This new sub-variant reportedly spots two new novel mutations that make it even more transmissible and immune evasive and is responsible for the large number of breakthrough infections. It is also said that this new sub-variant also replicates at an astounding rate once inside a human host, re...
Source: Manuka Honey-COVID-19  Oct 21, 2021  1 month ago
Manuka Honey-COVID-19: A new study by researchers from Qatar University has demonstrated that methylglyoxal (MG), a bioactive component in manuka honey exhibits virucidal properties against the SARS-CoV-2 coronavirus in vitro.   The study findings were published in the University’s website and has not been peer reviewed by any third parties yet. https://qspace.qu.edu.qa/handle/10576/24...
Source: SARS-CoV-2-Brain  Oct 21, 2021  1 month ago
SARS-CoV-2-Brain: A new MRI study by researchers from Saudi Arabia suggests pneumonia in COVID-19 patients is linked to viral-induced changes in the brain. MRI scans revealed that 57.9% of severe SARS-CoV-2 infected patients had recent brain lesions! The study findings provide further evidence that SAR-CoV-2 affects the brain and causes brain lesions and also generates various neurological manifes...
Source: Antithrombotics-COVID-19  Oct 21, 2021  1 month ago
Antithrombotics-COVID-19: A new multi-institutional clinical study has shown that antithrombotic therapy involving drugs like aspirin or apixaban is not warranted in COVID-19 outpatients. The researchers from Brigham and Women’s Hospital-Massachusetts, University of Pittsburgh-Pennsylvania, University of Illinois-Chicago, Intermountain Healthcare-Utah, National Heart, Lung, and Blood Instit...
Source: Singapore COVID-19 News  Oct 20, 2021  1 month ago
Singapore COVID-19 News: Not much was in the local Singapore mainstream news outlets about its record high 3,994 new COVID-19 cases in the last 24 hours with many representing breakthrough infections and even requiring hospitalizations and a few even died despite being double vaccinated!   The country has been reporting more than 3,000 daily SARS-CoV-2 infections in recent days.   It sh...
Source: COVId-19 Drugs  Oct 20, 2021  1 month ago
COVID-19 Drugs: A new multinational retrospective cohort study by researchers from Penn State College of Medicine, Pennsylvania-USA shows that glucose-regulating medications used to treat obesity and type-2 diabetes may improve outcomes in COVID-19 patients with type-2 diabetes. It has already been known that individuals with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-1...
Source: AY.4.2 Delta sub-variant  Oct 20, 2021  1 month ago
AY.4.2 Delta sub-variant: For the last 4 weeks, various U.S. agencies were trying to curtail and suppress any data with regards to the multitude of emerging Delta-sub-variants and even a lot of data were not stopped from being uploaded on online sharing platforms concerning emerging strains and variants. Of the more than 142 distinct Delta sub-variants found so far, some with concerning mutations ...
Source: COVID-19 Diagnostics  Oct 19, 2021  1 month ago
COVID-19 Diagnostics: Scientist from the department of chemistry at the University of Warwick-UK along with experts from Iceni Diagnostics Ltd-UK and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust-UK have developed and demonstrated a new diagnostic technology using sugars instead of antibodies to detect the SARS-CoV-2 coronavirus.   To date since the start of the COVID-19 pa...
Source: Obesity  Oct 18, 2021  2 months ago
A new breakthrough study by researchers From Okinawa Institute of Science and Technology (OIST) Graduate University-Japan and the Institute of Medical Science at the University of Tokyo-Japan have identified a brain protein that plays a key in how the brain regulates appetite and metabolism.   The study team found that loss of the protein, XRN1, from the forebrain, resulted in obese mice wit...
Source: Variant News  Oct 18, 2021  2 months ago
Variant News: Genomic researchers and virologists from the EVT Viral Genomics and Sequencing Lab at Louisiana State University (LSU) Health Shreveport are the first in America to sequence and report that a new variant of SARS-CoV-2, the coronavirus that causes COVID-19, has been detected in the state of Louisiana. According to the study team, the new B.1.630 variant, was sequenced last week from...
Source: SARS-CoV-2 Viral Persistence  Oct 17, 2021  2 months ago
SARS-CoV-2 Viral Persistence: The COVID-19 pandemic is the best thing that has happened to mankind so far as it shows how incompetent most medical researchers and physicians are and worst, those ignorant bureaucratic developing medical and treatment guidelines from diagnostics, treatments, clinical practices etc. It also reflects on even how stupid majority of the masses are in accepting things an...
Source: Stem Cell Therapies  Oct 16, 2021  2 months ago
A new study by researchers from University of California, Irvine-USA, University of Melbourne-Australia, Georgia Institute of Technology-USA and The State University of New York warns about the misinformation linked to ‘overhyped science’ on stem cell treatments for COVID-19.   Many previously published studies on stem cells claiming to be able to prevent or treat COVID-19 o...
Source: SARS-CoV-2-Sexual Transmissions  Oct 15, 2021  2 months ago
A new study by researchers from Columbia Mailman School of Public Health-Columbia University, New York and Columbia University Irving Medical Center-New York have confirmed that presence of the SARS-CoV-2 coronavirus in semen of infected males and also has found that infected males or those that had recovered had low sperm count! The study findings published in the U.S. CDC Journal: Emerging Infec...
Source: COVID-19 Drugs  Oct 15, 2021  2 months ago
COVID-19 Drugs: A new study that analyzes real-world data utilizing artificial intelligence by researchers from AdventHealth Research Institute-Orlando, Oak Ridge National Laboratory-Tennessee and the University of Tennessee has found that the antiemetic drug Zofran (Ondansetron) lowers risk of mortality of severe COVID-19 patients on ventilators and is associated with increased survival of these ...
Source: Long COVID  Oct 14, 2021  2 months ago
Long COVID is now becoming a more serious issue as initially certain earlier studies had found that only about 30 to 37 percent of people who were infected with the SARS-CoV-2 coronavirus will continue to suffer from a variety of long-term health/medical conditions known collectively as PASC or Post-acute Sequelae of COVID-19. However newer data is showing that not only are the medical conditions ...
Source: COVID-19 Immunology  Oct 14, 2021  2 months ago
COVID-19 Immunology: A new study by researchers from the University of Glassgow-Scotland, the Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Italy and the Università Cattolica del Sacro Cuore-Italy has identified that a macrophage induced protein called SPP1 as a mediator that is driving multiple pathogenic inflammatory responses in severe COVID-19 as well as in Long COVID. &nb...
Source: SARS-CoV-2 Research  Oct 13, 2021  2 months ago
Scientists from the Global Health Institute-School of Life Sciences, Lausanne-Switzerland have in a new study found that acylation of spike of SARS-CoV-2 enhances infectivity and also fusion capacity. Typically, SARS-CoV-2 virions are surrounded by a lipid bilayer that contains membrane proteins such as spike, responsible for target-cell binding and virus fusion.   The study team f...
Source: Toxic Chemicals And Human Health  Oct 13, 2021  2 months ago
Toxic Chemicals: A new study by researchers from at NYU Grossman School of Medicine has found that daily exposure to chemicals called phthalates, which are used in the manufacture of plastic food containers and many cosmetics, may lead to roughly 100,000 premature deaths among older Americans each year.   Interestingly most of the deaths were due to phthalate-induced heart issues and not can...
Source: SARS-CoV-2-Eyes-Long COVID  Oct 13, 2021  2 months ago
A new study by researchers from Max Planck Institute for Molecular Biomedicine has discovered that the SARS-CoV-2 coronavirus is able to infect and replicate in the photoreceptor and also retinal ganglion cells of human retinal organoids. Alarmingly the study findings not only suggest a retinal involvement in COVID 19 but also emphasize the need to monitor retinal pathologies as potential sequela...
Source: SARS-CoV-2 Research  Oct 12, 2021  2 months ago
A new study by researchers from University of South Florida-Tampa along with experts from James A Haley Veterans Hospital-Florida and Florida International University-Port St. Lucie have found that palmitoylation of the first five cysteine residues of the C-terminal domain of the SARS-CoV-2 spike protein is essential to SARS-CoV-2, facilitating cell entry and the formation of syncytia.   Pal...
Source: Phytochemical News  Oct 12, 2021  2 months ago
A new study by researchers from Penn State College of Medicine has found that the phytochemical cum antioxidant found in most common edible mushrooms ie Ergothioneine, lowers the risk for depression.   The consumption of mushrooms has been making headlines due to their many health advantages including lowering one's risk of cancer and premature death, but this new study findings now reve...
Source: Editorial  Oct 12, 2021  2 months ago
I cringe whenever I see stupid government leaders around the world making public statements like “We should learn to live with the SARS-CoV-2 coronavirus” or what certain so called health officials or so called “experts” are telling the masses that the COVID-19 disease will become endemic and that things will then become manageable or ok!” Only the even more stupid ma...
Source: Lipids And COVID-19   Oct 11, 2021  2 months ago
A new study by researchers from the University of Pennsylvania showed that that lipids pay a critical role in SARS-CoV-2 replication and human immune response.   According to the study abstract, “Lipids play essential roles in the viral life cycle. The lipid composition of cell membranes can influence viral entry by mediating fusion or affecting receptor conformation. Upon infection, v...
Source: Vaccine News  Oct 11, 2021  2 months ago
As of last Friday, the Health Directorate in Iceland issued a total suspension of the usage of the Moderna COVID-19 vaccine developed by a US pharmaceutical company due to concerns over increased risks of heart-inflammation.   Iceland joins a growing number of European countries including all four Nordic countries ie Sweden, Finland, Denmark and Norway that have either halted the usage of th...
Source: Phytochemicals To Treat COVID-19  Oct 10, 2021  2 months ago
Researchers from Friedrich-Alexander University Erlangen-Nürnberg-Germany and the University Hospital Tübingen-Germany along with experts from Marinomed Biotech AG-Austria are exploring the antiviral properties of a natural lectin from bread wheat (Triticum vulgaris) called Wheat Germ Agglutinin (WGA) to treat COVID-19.   Their study findings showed that the Wheat Germ Aggluti...
Source: Phytochemical News  Oct 10, 2021  2 months ago
Phytochemical News: A new study led by researchers from University of South Florida Health has discovered that the phytochemical compound Fenchol has the same beneficial effect as gut-derived metabolites such as short-chain fatty acids (SCFAs) in reducing neurotoxic amyloid-beta in the brain.   To date, multiple emerging evidence indicates that the gut microbiota contributes to the pathology...
Source: COVID-19 Immunology  Oct 09, 2021  2 months ago
COVID-19 Immunology: A new study by researchers from Harvard medical School and MIT has found that neutrophil dysregulation is observed in severe COVID and that IgA-dominant responses drive neutrophil effector functions causing disease severity and mortality.   The study team collected 781 longitudinal blood samples from 306 hospitalized COVID-19+ patients, 78 COVID-19− acute...
Source: Pfizer COVId-19 Vaccine  Oct 09, 2021  2 months ago
In a surprising new development, the elites controlling the narratives of the COVID-19 pandemic allowed the study findings of a two vaccine research investigations, one by scientists from Qatar and the second by researchers from Israel that alarmingly indicated that protection from the US COVID-19 vaccine by Pfizer may wane after only two months!    The studies were published in the pee...
Source: OAS1 Gene-COVID-19   Oct 08, 2021  2 months ago
OAS1 Gene and COVID-19: A new study by researchers from University of College London (UCL) has found that the OAS1 gene is a risk factor for bot the development of Alzheimer's Disease as well as COVID-19 severity.   The study team had previously reported that oligoadenylate synthetase 1 (OAS1) contributed to the risk of Alzheimer’s disease, by its enrichment in transcriptional...
Source: Long COVID-Kidney Disease   Oct 08, 2021  2 months ago
Long-COVID-Kidney Disease: While many morons out there are assuming that COVID-19 is nothing as serious as the common flu and that it only affects the old or obese or those with existing comorbidities, its going to be fun in coming months and years as we see more people who had once been infected with the SARS-CoV-2 coronavirus start developing not just the mild manifestations of Long COVID such a...
Source: Monoclonal Antibodies-SARS-CoV-2 Variants  Oct 07, 2021  2 months ago
Monoclonal Antibodies-SARS-CoV-2 Variants: If anything, the COVID-19 pandemic has revealed to those intelligent enough to understand anything that the elites in the United States are nothing more than the most filthy, unethical and greedy and corrupted live forms ever to emerge this earth.   From day one of the pandemic, certain American elites have been controlling the narratives of the COV...
Source: Long COVID Research  Oct 07, 2021  2 months ago
Long COVID Research: A new study by researchers from Icahn School of Medicine at Mount Sinai-New York shows that gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms.   Physicians and medical experts around the world are finally coming to terms that after 21 months into the COVID-19 pandemic, the post-acute sequelae of COVID-19 disease (PASC) or what are c...
Source: SARS-CoV-2 Emerging Variants  Oct 06, 2021  2 months ago
SARS-CoV-2 Emerging Variants: A new study by French researchers from the Institut Pasteur-Paris, Université de Paris, Vaccine Research Institute-France and Sorbonne Université-Paris has alarmingly found that the various new emerging SARS-CoV-2 variants display enhanced syncytia formation! These findings confirm that the emerging variants are getting more dangerous for humans!  ...

MOST READ

Feb 05, 2020  2 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 year ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 year ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 year ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  2 years ago
Source: Myocardial Injury
Jun 09, 2020  2 years ago
Source: COVID-19 News
May 21, 2020  2 years ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  2 years ago